The  ||| S:0 E:4 ||| DT
use  ||| S:4 E:8 ||| NN
of  ||| S:8 E:11 ||| IN
modified  ||| S:11 E:20 ||| NN
and  ||| S:20 E:24 ||| CC
non-natural  ||| S:24 E:36 ||| JJ
nucleotides  ||| S:36 E:48 ||| NNS
provide  ||| S:48 E:56 ||| VBP
unique  ||| S:56 E:63 ||| JJ
insights  ||| S:63 E:72 ||| NNS
into  ||| S:72 E:77 ||| IN
pro-mutagenic  ||| S:77 E:91 ||| JJ
replication  ||| S:91 E:103 ||| JJ
catalyzed  ||| S:103 E:113 ||| NN
by  ||| S:113 E:116 ||| IN
polymerase  ||| S:116 E:127 ||| NNS
eta  ||| S:127 E:131 ||| VBP
This  ||| S:131 E:136 ||| DT
report  ||| S:136 E:143 ||| NN
evaluates  ||| S:143 E:153 ||| VBZ
the  ||| S:153 E:157 ||| DT
pro-mutagenic  ||| S:157 E:171 ||| JJ
behavior  ||| S:171 E:180 ||| NN
of  ||| S:180 E:183 ||| IN
8-oxo-guanine  ||| S:183 E:197 ||| NNP
( ||| S:197 E:198 ||| -LRB-
8-oxo-G ||| S:198 E:205 ||| NNP
)  ||| S:205 E:207 ||| -RRB-
by  ||| S:207 E:210 ||| IN
quantifying  ||| S:210 E:222 ||| VBG
the  ||| S:222 E:226 ||| DT
ability  ||| S:226 E:234 ||| NN
of  ||| S:234 E:237 ||| IN
high-fidelity  ||| S:237 E:251 ||| NN
and  ||| S:251 E:255 ||| CC
specialized  ||| S:255 E:267 ||| JJ
DNA  ||| S:267 E:271 ||| NN
polymerases  ||| S:271 E:283 ||| NN
to  ||| S:283 E:286 ||| TO
incorporate  ||| S:286 E:298 ||| VB
natural  ||| S:298 E:306 ||| JJ
and  ||| S:306 E:310 ||| CC
modified  ||| S:310 E:319 ||| JJ
nucleotides  ||| S:319 E:331 ||| NN
opposite  ||| S:331 E:340 ||| IN
this  ||| S:340 E:345 ||| DT
lesion ||| S:345 E:351 ||| NN
.  ||| S:351 E:353 ||| .
Although  ||| S:353 E:362 ||| IN
high-fidelity  ||| S:362 E:376 ||| NN
DNA  ||| S:376 E:380 ||| NN
polymerases  ||| S:380 E:392 ||| VBZ
such  ||| S:392 E:397 ||| JJ
as  ||| S:397 E:400 ||| IN
pol  ||| S:400 E:404 ||| JJ
δ  ||| S:404 E:406 ||| NN
and  ||| S:406 E:410 ||| CC
the  ||| S:410 E:414 ||| DT
bacteriophage  ||| S:414 E:428 ||| JJ
T4  ||| S:428 E:431 ||| NNP
DNA  ||| S:431 E:435 ||| NNP
polymerase  ||| S:435 E:446 ||| FW
replicating  ||| S:446 E:458 ||| FW
8-oxo-G  ||| S:458 E:466 ||| FW
in  ||| S:466 E:469 ||| IN
an  ||| S:469 E:472 ||| DT
error-prone  ||| S:472 E:484 ||| JJ
manner ||| S:484 E:490 ||| NN
,  ||| S:490 E:492 ||| ,
they  ||| S:492 E:497 ||| PRP
display  ||| S:497 E:505 ||| VBP
remarkably  ||| S:505 E:516 ||| RB
low  ||| S:516 E:520 ||| JJ
efficiencies  ||| S:520 E:533 ||| NNS
for  ||| S:533 E:537 ||| IN
TLS  ||| S:537 E:541 ||| NNP
compared  ||| S:541 E:550 ||| VBN
to  ||| S:550 E:553 ||| TO
normal  ||| S:553 E:560 ||| JJ
DNA  ||| S:560 E:564 ||| NN
synthesis ||| S:564 E:573 ||| NN
.  ||| S:573 E:575 ||| .
In  ||| S:575 E:578 ||| IN
contrast ||| S:578 E:586 ||| NN
,  ||| S:586 E:588 ||| ,
pol  ||| S:588 E:592 ||| JJ
η  ||| S:592 E:594 ||| NN
shows  ||| S:594 E:600 ||| VBZ
a  ||| S:600 E:602 ||| DT
combination  ||| S:602 E:614 ||| NN
of  ||| S:614 E:617 ||| IN
high  ||| S:617 E:622 ||| JJ
efficiency  ||| S:622 E:633 ||| NN
and  ||| S:633 E:637 ||| CC
low  ||| S:637 E:641 ||| JJ
fidelity  ||| S:641 E:650 ||| NN
when  ||| S:650 E:655 ||| WRB
replicating  ||| S:655 E:667 ||| JJ
8-oxo-G ||| S:667 E:674 ||| NN
.  ||| S:674 E:676 ||| .
These  ||| S:676 E:682 ||| DT
combined  ||| S:682 E:691 ||| JJ
properties  ||| S:691 E:702 ||| NNS
are  ||| S:702 E:706 ||| VBP
consistent  ||| S:706 E:717 ||| JJ
with  ||| S:717 E:722 ||| IN
a  ||| S:722 E:724 ||| DT
pro-mutagenic  ||| S:724 E:738 ||| JJ
role  ||| S:738 E:743 ||| NN
for  ||| S:743 E:747 ||| IN
pol  ||| S:747 E:751 ||| JJ
η  ||| S:751 E:753 ||| NN
when  ||| S:753 E:758 ||| WRB
replicating  ||| S:758 E:770 ||| VBG
this  ||| S:770 E:775 ||| DT
DNA  ||| S:775 E:779 ||| NN
lesion ||| S:779 E:785 ||| NN
.  ||| S:785 E:787 ||| .
Studies  ||| S:787 E:795 ||| NNS
using  ||| S:795 E:801 ||| VBG
modified  ||| S:801 E:810 ||| VBN
nucleotide  ||| S:810 E:821 ||| JJ
analogs  ||| S:821 E:829 ||| JJ
show  ||| S:829 E:834 ||| NN
that  ||| S:834 E:839 ||| IN
pol  ||| S:839 E:843 ||| JJ
η  ||| S:843 E:845 ||| NN
relies  ||| S:845 E:852 ||| VBZ
heavily  ||| S:852 E:860 ||| RB
on  ||| S:860 E:863 ||| IN
hydrogen-bonding  ||| S:863 E:880 ||| JJ
interactions  ||| S:880 E:893 ||| NNS
during  ||| S:893 E:900 ||| IN
translesion  ||| S:900 E:912 ||| JJ
DNA  ||| S:912 E:916 ||| NN
synthesis ||| S:916 E:925 ||| NN
.  ||| S:925 E:927 ||| .
However ||| S:927 E:934 ||| RB
,  ||| S:934 E:936 ||| ,
nucleobase  ||| S:936 E:947 ||| JJ
modifications  ||| S:947 E:961 ||| NNS
such  ||| S:961 E:966 ||| JJ
as  ||| S:966 E:969 ||| IN
alkylation  ||| S:969 E:980 ||| VBG
to  ||| S:980 E:983 ||| TO
the  ||| S:983 E:987 ||| DT
N2  ||| S:987 E:990 ||| JJ
position  ||| S:990 E:999 ||| NN
of  ||| S:999 E:1002 ||| IN
guanine  ||| S:1002 E:1010 ||| VBG
significantly  ||| S:1010 E:1024 ||| RB
increase  ||| S:1024 E:1033 ||| VB
error-prone  ||| S:1033 E:1045 ||| JJ
synthesis  ||| S:1045 E:1055 ||| JJ
catalyzed  ||| S:1055 E:1065 ||| NN
by  ||| S:1065 E:1068 ||| IN
pol  ||| S:1068 E:1072 ||| JJ
η  ||| S:1072 E:1074 ||| NN
when  ||| S:1074 E:1079 ||| WRB
replicating  ||| S:1079 E:1091 ||| JJ
8-oxo-G ||| S:1091 E:1098 ||| NN
.  ||| S:1098 E:1100 ||| .
Molecular  ||| S:1100 E:1110 ||| JJ
modeling  ||| S:1110 E:1119 ||| NN
studies  ||| S:1119 E:1127 ||| NNS
demonstrate  ||| S:1127 E:1139 ||| VBP
the  ||| S:1139 E:1143 ||| DT
existence  ||| S:1143 E:1153 ||| NN
of  ||| S:1153 E:1156 ||| IN
a  ||| S:1156 E:1158 ||| DT
hydrophobic  ||| S:1158 E:1170 ||| JJ
pocket  ||| S:1170 E:1177 ||| NN
in  ||| S:1177 E:1180 ||| IN
pol  ||| S:1180 E:1184 ||| JJ
η  ||| S:1184 E:1186 ||| NN
that  ||| S:1186 E:1191 ||| WDT
participates  ||| S:1191 E:1204 ||| VBZ
in  ||| S:1204 E:1207 ||| IN
the  ||| S:1207 E:1211 ||| DT
increased  ||| S:1211 E:1221 ||| JJ
utilization  ||| S:1221 E:1233 ||| NN
of  ||| S:1233 E:1236 ||| IN
certain  ||| S:1236 E:1244 ||| JJ
hydrophobic  ||| S:1244 E:1256 ||| JJ
nucleotides ||| S:1256 E:1267 ||| NN
.  ||| S:1267 E:1269 ||| .
A  ||| S:1269 E:1271 ||| DT
model  ||| S:1271 E:1277 ||| NN
is  ||| S:1277 E:1280 ||| VBZ
proposed  ||| S:1280 E:1289 ||| VBN
for  ||| S:1289 E:1293 ||| IN
enhanced  ||| S:1293 E:1302 ||| JJ
pro-mutagenic  ||| S:1302 E:1316 ||| JJ
replication  ||| S:1316 E:1328 ||| JJ
catalyzed  ||| S:1328 E:1338 ||| NN
by  ||| S:1338 E:1341 ||| IN
pol  ||| S:1341 E:1345 ||| JJ
η  ||| S:1345 E:1347 ||| NN
that  ||| S:1347 E:1352 ||| IN
couples  ||| S:1352 E:1360 ||| NNS
efficient  ||| S:1360 E:1370 ||| JJ
incorporation  ||| S:1370 E:1384 ||| NN
of  ||| S:1384 E:1387 ||| IN
damaged  ||| S:1387 E:1395 ||| JJ
nucleotides  ||| S:1395 E:1407 ||| JJ
opposite  ||| S:1407 E:1416 ||| JJ
oxidized  ||| S:1416 E:1425 ||| JJ
DNA  ||| S:1425 E:1429 ||| NN
lesions  ||| S:1429 E:1437 ||| VBZ
created  ||| S:1437 E:1445 ||| VBN
by  ||| S:1445 E:1448 ||| IN
reactive  ||| S:1448 E:1457 ||| JJ
oxygen  ||| S:1457 E:1464 ||| NN
species ||| S:1464 E:1471 ||| NNS
.  ||| S:1471 E:1473 ||| .
The  ||| S:1473 E:1477 ||| DT
biological  ||| S:1477 E:1488 ||| JJ
implications  ||| S:1488 E:1501 ||| NNS
of  ||| S:1501 E:1504 ||| IN
this  ||| S:1504 E:1509 ||| DT
model  ||| S:1509 E:1515 ||| NN
toward  ||| S:1515 E:1522 ||| IN
increasing  ||| S:1522 E:1533 ||| VBG
mutagenic  ||| S:1533 E:1543 ||| JJ
events  ||| S:1543 E:1550 ||| NNS
in  ||| S:1550 E:1553 ||| IN
lung  ||| S:1553 E:1558 ||| NN
cancer  ||| S:1558 E:1565 ||| NN
are  ||| S:1565 E:1569 ||| VBP
discussed ||| S:1569 E:1578 ||| VBN
.  ||| S:1578 E:1580 ||| .
